Compass Therapeutics Inc.
(CMPX)
undefined
undefined%
At close: undefined
1.46
0.34%
After-hours Dec 13, 2024, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
Revenue | - | - | - | - | - | - |
Cost of Revenue | 1.89M | 1.90M | 1.62M | 2.40M | 2.12M | 1.92M |
Gross Profit | -1.89M | -1.90M | -1.62M | -2.40M | -2.12M | -1.92M |
Operating Income | -50.36M | -41.66M | -81.88M | -27.81M | -34.05M | -38.31M |
Interest Income | - | 2.36M | 29.00K | 88.00K | 743.00K | 663.00K |
Pretax Income | -42.49M | -39.23M | -82.18M | -29.47M | -34.65M | -38.18M |
Net Income | -42.49M | -36.80M | -82.55M | -29.50M | -34.74M | -38.29M |
Selling & General & Admin | 11.05M | 11.66M | 10.93M | 12.91M | 11.60M | 11.22M |
Research & Development | 37.42M | 30.00M | 20.34M | 14.90M | 22.45M | 27.09M |
Other Expenses | - | - | 50.62M | - | - | - |
Operating Expenses | 48.47M | 41.66M | 31.26M | 27.81M | 34.05M | 38.31M |
Interest Expense | - | 2.36M | 370.00K | 908.00K | 1.23M | 767.00K |
Selling & Marketing Expenses | 11.04M | - | - | - | - | - |
Cost & Expenses | 50.36M | 41.66M | 31.26M | 27.81M | 34.05M | 38.31M |
Income Tax | - | -2.43M | 370.00K | 32.00K | 91.00K | 103.00K |
Shares Outstanding (Basic) | 127.03M | 105.19M | 62.87M | 30.78M | 52.11M | 52.11M |
Shares Outstanding (Diluted) | 127.03M | 105.19M | 62.87M | 30.78M | 52.11M | 52.11M |
EPS (Basic) | -0.33 | -0.35 | -1.31 | -0.96 | -0.67 | -0.73 |
EPS (Diluted) | -0.33 | -0.35 | -1.31 | -0.96 | -0.67 | -0.73 |
EBITDA | -48.47M | -37.39M | -29.61M | -25.32M | -31.19M | -35.73M |
Depreciation & Amortization | 1.89M | 1.90M | 1.62M | 2.40M | 2.12M | 1.92M |